Clare Johnson

943 total citations
21 papers, 613 citations indexed

About

Clare Johnson is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Clare Johnson has authored 21 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Clare Johnson's work include Cutaneous Melanoma Detection and Management (13 papers), Melanoma and MAPK Pathways (12 papers) and CAR-T cell therapy research (4 papers). Clare Johnson is often cited by papers focused on Cutaneous Melanoma Detection and Management (13 papers), Melanoma and MAPK Pathways (12 papers) and CAR-T cell therapy research (4 papers). Clare Johnson collaborates with scholars based in United States and United Kingdom. Clare Johnson's co-authors include Robert W. Cook, Kristen M. Oelschlager, Derek Maetzold, Pedram Gerami, Jeff Wilkinson, John F. Stone, Keith A. Delman, Rodabe N. Amaria, Brooke Middlebrook and René González and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of the American Academy of Dermatology.

In The Last Decade

Clare Johnson

21 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clare Johnson United States	9	498	385	123	100	57	21	613
Derek Maetzold United States	9	433 0.9×	340 0.9×	99 0.8×	97 1.0×	48 0.8×	18	539
Jeff Wilkinson United States	7	356 0.7×	279 0.7×	83 0.7×	93 0.9×	37 0.6×	10	445
Christine Longvert France	12	353 0.7×	233 0.6×	71 0.6×	106 1.1×	42 0.7×	34	525
Lygia Accioly Tinoco United States	4	363 0.7×	165 0.4×	103 0.8×	76 0.8×	51 0.9×	4	385
Angana Mitra United Kingdom	9	334 0.7×	219 0.6×	88 0.7×	122 1.2×	43 0.8×	14	489
Dennis L. Rousseau United States	9	372 0.7×	304 0.8×	125 1.0×	57 0.6×	47 0.8×	14	648
G. A. Farago Australia	10	598 1.2×	238 0.6×	124 1.0×	103 1.0×	157 2.8×	13	694
Erica B. Friedman United States	10	221 0.4×	209 0.5×	49 0.4×	89 0.9×	36 0.6×	27	450
Burkhard Bueltmann Germany	6	252 0.5×	121 0.3×	90 0.7×	74 0.7×	47 0.8×	10	318
John W Kelly Australia	11	208 0.4×	112 0.3×	78 0.6×	32 0.3×	70 1.2×	23	327

Countries citing papers authored by Clare Johnson

Since Specialization

Citations

This map shows the geographic impact of Clare Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare Johnson more than expected).

Fields of papers citing papers by Clare Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clare Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare Johnson. The network helps show where Clare Johnson may publish in the future.

Co-authorship network of co-authors of Clare Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Clare Johnson. A scholar is included among the top collaborators of Clare Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clare Johnson. Clare Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Borman, Sherri, Jeff Wilkinson, Clare Johnson, et al.. (2022). Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients. Diagnostic Pathology. 17(1). 32–32. 5 indexed citations

Farberg, Aaron S., Christine A. Bailey, Clare Johnson, et al.. (2020). A 35-Gene Expression Profile Test for use in Suspicious Pigmented Lesions Impacts Clinical Management Decisions of Dermatopathologists and Dermatologists. SKIN The Journal of Cutaneous Medicine. 4(6). 523–533. 1 indexed citations

Hyams, David M., et al.. (2020). Integrating the Melanoma 31-Gene Expression Profile Test with Surgical Oncology Practice Within National Guideline and Staging Recommendations. Future Oncology. 17(5). 517–527. 6 indexed citations

Davidson, Robert S., Kyle R. Covington, Robert W. Cook, et al.. (2018). Prospective, Multicenter Clinical Impact Evaluation of a 31-Gene Expression Profile Test for Management of Melanoma Patients. SKIN The Journal of Cutaneous Medicine. 2(2). 111–121. 24 indexed citations

Hsueh, Eddy C., James R. DeBloom, Jonathan Lee, et al.. (2017). Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test. Journal of Hematology & Oncology. 10(1). 152–152. 66 indexed citations

Ferris, Laura K., Aaron S. Farberg, Brooke Middlebrook, et al.. (2017). Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile–based classification. Journal of the American Academy of Dermatology. 76(5). 818–825.e3. 41 indexed citations

Rienzo, Assunta De, Robert W. Cook, Jeff Wilkinson, et al.. (2016). Validation of a Gene Expression Test for Mesothelioma Prognosis in Formalin-Fixed Paraffin-Embedded Tissues. Journal of Molecular Diagnostics. 19(1). 65–71. 8 indexed citations

Berger, Adam C., Robert S. Davidson, Indy Chabra, et al.. (2016). Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients. Current Medical Research and Opinion. 32(9). 1599–1604. 51 indexed citations

Cook, Robert W., Tony Tsai, Yevgeniy Shildkrot, et al.. (2016). Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study. Journal of Oncology. 2016. 1–9. 36 indexed citations

10.

Meldi, Kristen, Robert W. Cook, Tony Tsai, et al.. (2016). A prospective, multi-center study to evaluate the performance and clinical utility of a 15-gene expression profile for uveal melanoma.. Journal of Clinical Oncology. 34(15_suppl). 9575–9575. 1 indexed citations

11.

Gerami, Pedram, Robert W. Cook, Maria C. Russell, et al.. (2015). Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy. Journal of the American Academy of Dermatology. 72(5). 780–785.e3. 116 indexed citations

12.

Gerami, Pedram, Robert W. Cook, Jeff Wilkinson, et al.. (2015). Development of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous Melanoma. Clinical Cancer Research. 21(1). 175–183. 194 indexed citations

13.

Shan, Weiwei, Daniel C. Rosen, Natalie Lassen, et al.. (2015). Prospective prediction of resistance to neoadjuvant therapy in patients with locoregional esophageal adenocarcinoma. 53–53. 1 indexed citations

14.

Lawson, David H., Robert W. Cook, Clare Johnson, et al.. (2015). Continued evaluation of a 31-gene expression profile test (GEP) for prediction of distant metastasis (DM) in cutaneous melanoma (CM).. Journal of Clinical Oncology. 33(15_suppl). 9066–9066. 6 indexed citations

15.

Skelly, Rob, Lisa Brown, Apostolos Fakis, et al.. (2014). Does a specialist unit improve outcomes for hospitalized patients with Parkinson's disease?. Parkinsonism & Related Disorders. 20(11). 1242–1247. 28 indexed citations

16.

Shan, Weiwei, Natalie Lassen, Clare Johnson, et al.. (2014). A proprietary multianalyte test for predicting extreme resistance to neoadjuvant 5-FU based chemoradiation (CTRT) in esophageal adenocarcinoma (EC).. Journal of Clinical Oncology. 32(3_suppl). 51–51. 2 indexed citations

17.

Badve, Sunil, Weiwei Shan, Clare Johnson, et al.. (2014). A proprietary multi-analyte test to predict neoadjuvant treatment response for esophageal and rectal adenocarcinoma patients.. Journal of Clinical Oncology. 32(15_suppl). 4085–4085. 1 indexed citations

18.

Lawson, David H., Maria C. Russell, Jeff Wilkinson, et al.. (2014). Gene expression profile test (GEP) prediction of metastasis-free (MFS) and overall survival (OS) in a cohort of cutaneous melanoma (CM) patients undergoing sentinel lymph node biopsy (SLNB).. Journal of Clinical Oncology. 32(15_suppl). 9022–9022. 2 indexed citations

19.

Lawson, David H., Maria C. Russell, Jeffrey Wilkinson, et al.. (2013). Gene expression profile of primary cutaneous melanomas to distinguish between low and high risk of metastasis.. Journal of Clinical Oncology. 31(15_suppl). 9022–9022. 2 indexed citations

20.

Johnson, Clare, et al.. (1995). Testicular toxicity of the transferrin binding radionuclide 114min in adult and neonatal rats. Reproductive Toxicology. 9(3). 297–305. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact